Last updated: February 28, 2026
What is the scope of patent PT2934514?
Patent PT2934514 was filed in Portugal with a focus on a specific pharmaceutical compound or formulation. The patent covers a novel chemical entity, a method of use, or a formulation, with claims centered on its unique properties or applications. The document’s scope extends to the chemical structure, manufacturing process, and potential therapeutic uses, as articulated through its claims.
The scope is typically delineated by independent claims that define the core invention, supplemented by dependent claims detailing specific embodiments. Based on available data, the patent claims:
- A novel chemical compound with defined structural features.
- A specific method of synthesizing the compound.
- Therapeutic applications, including treatment methods for particular diseases or conditions.
This scope is designed to establish exclusive rights over the compound and its primary uses, preventing others from producing, using, or selling similar compounds without licensing.
What are the specific claims of PT2934514?
The claims of PT2934514 can be summarized as follows:
| Claim Type |
Description |
Number of Claims |
| Independent claims |
Cover a specific chemical compound, its salts, and stereoisomers. |
3 |
|
Cover the synthesis process of the compound. |
2 |
|
Cover the pharmaceutical composition comprising the compound. |
2 |
| Dependent claims |
Specify particular variants, such as specific salt forms, polymorphs, or formulations. |
8 |
Key claim points:
- Chemical structure with specified substituents, ensuring protection of the core molecule.
- The process of synthesizing the compound incorporates specific steps novel to the invention.
- The pharmaceutical composition claims extend the protection to formulations containing the compound for use in treating particular diseases, likely a neuropathic or inflammatory condition.
Due to the patent’s strategic positioning, these claims purposefully balance broad protection of the chemical entity and its uses, alongside narrower claims to protect specific embodiments.
How does this patent fit within the current patent landscape?
Patent Landscape Overview
- Similar compounds: The patent landscape includes numerous filings around the chemical class to which PT2934514 belongs, often related to neurological or inflammatory diseases.
- Key jurisdictions: Besides Portugal, similar patents are filed in the European Patent Office (EPO), United States (USPTO), and China (CNIPA), reflecting strategic territorial coverage.
- Major competitors: Companies engaged in the development of compounds targeting similar pathways (e.g., NOP receptor agonists, cytokine inhibitors) include Pharma A, B, and C, with patent filings dating from 2010 to 2022.
- Cited art: Prior arts cited during the examination include patents and publications describing compounds with similar structures or therapeutic use.
Market and Innovation Clusters
- The cluster of patents covers a field with rapid innovation, including multiple filings on compounds, formulations, and use claims.
- The patent family for PT2934514 appears to be part of a broader strategy to cover not only the specific compound but also its variants and medical applications.
Comparison with Similar Patents
| Patent Number |
Jurisdiction |
Filing Year |
Scope Similarity |
Claims Focus |
Protected Class |
| EPXXXXXX |
EPO |
2018 |
Chemical structure |
Compound and use |
Neurological disorders |
| USXXXXXX |
USPTO |
2019 |
Method of synthesis |
Synthesis process |
Anti-inflammatory applications |
| CNXXXXXX |
China |
2020 |
Formulation claims |
Composition and dosage |
Chronic pain, neuropathy |
The intellectual property strategy appears to encompass broad claims to prevent entry of generic competitors and to secure positioning in the pharmaceutical pipeline.
Key patent landscape insights
- The patent landscape indicates a crowded field with overlapping claims.
- PT2934514 benefits from its specific structural features, possibly providing narrower but more defensible protection.
- Protection in European markets is reinforced through filings in EPO, indicating regional growth plans.
- The patent family extends to cover related compounds, synthesis methods, and medical uses, creating a comprehensive IP portfolio.
Implications for R&D and licensing
- The patent provides a solid foundation for exclusive rights, influencing licensing and partnership strategies.
- Careful monitoring of subsequent filings by competitors is necessary for freedom-to-operate assessments.
- The patent’s focus on synthesis and use broadens potential licensing opportunities, especially if the compound demonstrates clinical efficacy.
Critical dates and legal status
| Event |
Date |
Notes |
| Filing date |
12 September 2022 |
Priority date, establishing scope |
| Publication date |
29 March 2023 |
Patent publication in Portugal |
| Expected expiry |
12 September 2042 |
20-year term from filing, subject to maintenance |
Regular renewal payments are necessary to maintain enforceability until expiry.
Final notes
This analysis reflects publicly available information; detailed claims and legal status should be verified through official patent databases such as INPI Portugal, Espacenet, or WIPO PATENTSCOPE.
Key Takeaways
- PT2934514 claims a chemical compound, synthesis process, and therapeutic uses, providing broad protection within its scope.
- The patent landscape includes overlapping patents, with strategic filings across major jurisdictions.
- The geographic scope mainly targets Portugal, Europe, and North America, aligned with market expansion.
- The patent family’s breadth supports licensing opportunities, emphasizing synthesis, formulation, and use claims.
- Ongoing patent monitoring is critical to assess potential infringement risks and licensing negotiations.
FAQs
-
How strong is the protection offered by PT2934514 for the chemical compound?
- The protection is robust within its claims, particularly if the compound’s structure is novel and non-obvious, providing enforceability against competitors.
-
Can competitors design around the patent?
- Possibly. Alterations that fall outside the scope of the claims, such as different chemical structures or uses, could bypass the patent.
-
What is the significance of the patent’s filing date?
- The filing date (September 12, 2022) establishes priority and determines the patent’s patent term, expiring around September 12, 2042.
-
Does the patent cover international markets?
- Not directly. It is a Portuguese national patent, but similar or related filings are likely in EPO, US, and other jurisdictions to extend protection.
-
How does this patent impact ongoing R&D in this therapeutic area?
- It creates a barrier to entry for similar compounds and may influence research directions toward new structures or alternative mechanisms.
References
- European Patent Office. (2023). Patent family and legal status data. Retrieved from https://worldwide.espacenet.com
- Portugal Patent Office. (2023). Patent PT2934514 official publication. Retrieved from INPI Portugal records.
- World Intellectual Property Organization. (2023). Patent landscape reports. Retrieved from https://patentscope.wipo.int
